Home / Tobramycin / Belgium
BE ATC S01AA12 · updated 3 Nov 2026
Tobramycin shortage in Belgium
Is there a Tobramycin shortage in Belgium?
Yes. As of 3 Nov 2026, 1 Tobramycin product is reported short in Belgium. The company estimate for the return is 14 Jan 2027. Main reason: manufacturing problem.
Also short in Canada, Spain, Austria, Czechia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Tobrex 0.3 % eye ointm. 3.5 g anticipated | Novartis Pharma | 13 Nov 2026 | 14 Jan 2027 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.